390 related articles for article (PubMed ID: 20202122)
1. Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration.
Gendron TF; Josephs KA; Petrucelli L
Neuropathol Appl Neurobiol; 2010 Apr; 36(2):97-112. PubMed ID: 20202122
[TBL] [Abstract][Full Text] [Related]
2. Rodent models of TDP-43 proteinopathy: investigating the mechanisms of TDP-43-mediated neurodegeneration.
Gendron TF; Petrucelli L
J Mol Neurosci; 2011 Nov; 45(3):486-99. PubMed ID: 21811811
[TBL] [Abstract][Full Text] [Related]
3. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases.
Warraich ST; Yang S; Nicholson GA; Blair IP
Int J Biochem Cell Biol; 2010 Oct; 42(10):1606-9. PubMed ID: 20601083
[TBL] [Abstract][Full Text] [Related]
4. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis.
Kwong LK; Uryu K; Trojanowski JQ; Lee VM
Neurosignals; 2008; 16(1):41-51. PubMed ID: 18097159
[TBL] [Abstract][Full Text] [Related]
5. Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies.
Miguel L; Frébourg T; Campion D; Lecourtois M
Neurobiol Dis; 2011 Feb; 41(2):398-406. PubMed ID: 20951205
[TBL] [Abstract][Full Text] [Related]
6. TAR DNA-binding protein 43 in neurodegenerative disease.
Chen-Plotkin AS; Lee VM; Trojanowski JQ
Nat Rev Neurol; 2010 Apr; 6(4):211-20. PubMed ID: 20234357
[TBL] [Abstract][Full Text] [Related]
7. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
Vanden Broeck L; Callaerts P; Dermaut B
Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
[TBL] [Abstract][Full Text] [Related]
8. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
9. RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy.
Ihara R; Matsukawa K; Nagata Y; Kunugi H; Tsuji S; Chihara T; Kuranaga E; Miura M; Wakabayashi T; Hashimoto T; Iwatsubo T
Hum Mol Genet; 2013 Nov; 22(22):4474-84. PubMed ID: 23804749
[TBL] [Abstract][Full Text] [Related]
10. TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Baloh RH
FEBS J; 2011 Oct; 278(19):3539-49. PubMed ID: 21777387
[TBL] [Abstract][Full Text] [Related]
11. [TDP-43 proteinopathies - from frontotemporal lobar degeneration to inclusion body myositis].
Kierdaszuk B; Berdyński M; Zekanowski C; Kamińska A
Neurol Neurochir Pol; 2012; 46(4):384-91. PubMed ID: 23023438
[TBL] [Abstract][Full Text] [Related]
12. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
[TBL] [Abstract][Full Text] [Related]
13. TDP-43 aggregation in neurodegeneration: are stress granules the key?
Dewey CM; Cenik B; Sephton CF; Johnson BA; Herz J; Yu G
Brain Res; 2012 Jun; 1462():16-25. PubMed ID: 22405725
[TBL] [Abstract][Full Text] [Related]
14. A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects.
Langellotti S; Romano V; Romano G; Klima R; Feiguin F; Cragnaz L; Romano M; Baralle FE
Dis Model Mech; 2016 Jun; 9(6):659-69. PubMed ID: 27101846
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and mis-metabolism of the neuropathological signature protein TDP-43.
Huang CC; Bose JK; Majumder P; Lee KH; Huang JT; Huang JK; Shen CK
J Cell Sci; 2014 Jul; 127(Pt 14):3024-38. PubMed ID: 24860144
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 in aging and Alzheimer's disease - a review.
Wilson AC; Dugger BN; Dickson DW; Wang DS
Int J Clin Exp Pathol; 2011 Jan; 4(2):147-55. PubMed ID: 21326809
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice.
Medina DX; Orr ME; Oddo S
Neurobiol Aging; 2014 Jan; 35(1):79-87. PubMed ID: 23954172
[TBL] [Abstract][Full Text] [Related]
18. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
Prudlo J
Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
[TBL] [Abstract][Full Text] [Related]
19. [A new dementia group caused by TDP-43 abnormality].
Arai T; Hosokawa M; Hasegawa M; Akiyama H; Asada T
Seishin Shinkeigaku Zasshi; 2011; 113(6):574-83. PubMed ID: 21815469
[TBL] [Abstract][Full Text] [Related]
20. PABPN1 suppresses TDP-43 toxicity in ALS disease models.
Chou CC; Alexeeva OM; Yamada S; Pribadi A; Zhang Y; Mo B; Williams KR; Zarnescu DC; Rossoll W
Hum Mol Genet; 2015 Sep; 24(18):5154-73. PubMed ID: 26130692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
